Gullick, W.J. (2003) c-erbB-4/HER4: friend or foe? Journal of Pathology, 200 (3). pp. 279-281. ISSN 0022-3417.
Restricted to Repository staff only
| Contact us about this Publication
The c-erbB-4 receptor has ligand stimulated tyrosine kinase activity but reports differ as to whether it induces cell division or differentiation. There is also controversy regarding its role in breast cancer, with some reports associating overexpression with short survival and others with longer life.
|Uncontrolled keywords:||growth factor • growth factor receptor • tyrosine kinase inhibition • signal transduction • breast cancer|
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
|Divisions:||Faculties > Science Technology and Medical Studies > School of Biosciences > Biomedical Research Group|
|Depositing User:||Bill Gullick|
|Date Deposited:||04 Sep 2008 00:01|
|Last Modified:||05 Sep 2011 23:34|
|Resource URI:||http://kar.kent.ac.uk/id/eprint/3983 (The current URI for this page, for reference purposes)|
- Depositors only (login required):